Take advantage of the latest tools, techniques, and deep healthcare expertise to create scalable resources, precision insights, and actionable ideas.


Explore our latest white paper, where we dive into the unique challenges and opportunities in the rare disease market. We provide invaluable insights into the complexities of launching orphan medicines and the strategies to achieve launch excellence. Discover how to navigate the complex landscape of rare disease markets, overcome post-pandemic hurdles, and achieve launch success.
In this white paper, EMEA Thought Leadership evolves the three pillars of launch excellence in rare diseases: stakeholder engagement, health system readiness, and value evidence.
Download the white paper to learn from the most successful rare disease launches.
Take advantage of the latest tools, techniques, and deep healthcare expertise to create scalable resources, precision insights, and actionable ideas.
Discover proven strategies and insights refined over more than 5,000 launches around the world.